All stock lists
Unlock the score
Precigen, Inc. (NASDAQ:PGEN)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
6.04
Insider Score
/ 100
PGEN Insider Score
PRECIGEN, INC. has a live Insider Score.
Scored on 1 qualifying trade from 1 insider in the last 90 days.
Financial Health Score
Weak
From PGEN’s reported statements · Q2 2026 (trailing 12 months)
Profitability0 / 20
Loses money on what it sells.
- Revenue
- $85.7M
- Net income
- -$157.7M
- Net margin
- -184.0%
Leverage0 / 20
Heavily indebted for what it earns.
- Total debt
- $98.3M
- Cash
- $16.3M
- Debt / equity
- 2.26
Liquidity20 / 20
Comfortably covers what is due within a year.
- Current assets
- $134.4M
- Current liabilities
- $29.4M
- Current ratio
- 4.58
Cash generation0 / 20
Consumes cash and must keep raising it.
- Operating cash flow
- -$114.2M
- Free cash flow
- -$115.8M
- FCF margin
- -135.1%
Dilution & runway0 / 20
Burning cash with under a year of runway — expect a raise.
- Shares outstanding
- 356.9M
- Share growth (1y)
- 20.4%
- Cash runway
- 2 months
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
PGEN Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 54.98 M | 23.25 M | 4.57 M | 2.92 M | 856.00 K | 1.34 M |
| Revenue Growth (YoY) | 6322.66 % | 1633.93 % | 283.61 % | 206.61 % | 19.39 % | 25.92 % |
| Cost of Revenue | 2.81 M | 2.88 M | 1.91 M | 1.35 M | 1.55 M | 1.42 M |
| Gross Profit | 52.17 M | 20.38 M | 2.65 M | 1.57 M | -699.00 K | -78.00 K |
| SG&A Expense | 22.25 M | 21.05 M | 17.64 M | 23.99 M | 0.00 | 12.36 M |
| R&D Expense | 7.28 M | 5.32 M | 6.67 M | 12.06 M | 11.49 M | 10.16 M |
| Operating Expenses | 29.53 M | 26.37 M | 24.32 M | 36.05 M | 31.07 M | 22.52 M |
| Operating Income | 22.64 M | -5.99 M | -21.67 M | -34.48 M | -31.76 M | -22.60 M |
| Pretax Income | 20.07 M | -7.93 M | -23.50 M | -146.34 M | -26.64 M | -54.15 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 3.00 K | 0.00 |
| Net Income | 20.07 M | -7.93 M | -23.50 M | -146.34 M | -26.64 M | -54.15 M |
| EPS (Basic) | 0.06 | -0.03 | -0.07 | -1.10 | -0.09 | -0.18 |
| EPS (Diluted) | 0.05 | -0.03 | -0.07 | -1.10 | -0.09 | -0.18 |
| Shares Outstanding | 356.89 M | 312.98 M | 312.98 M | 296.43 M | 296.43 M | 293.88 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.